ClinicalTrials.Veeva

Menu

Evaluation of Vital Capacity (CVassist)

C

Centre d'Investigation Clinique et Technologique 805

Status and phase

Terminated
Phase 2

Conditions

Respiration Disorders
Neuromuscular Disease

Treatments

Device: measures of assisted vital capacity by a mechanical insufflation/exsufflation (Cough Assist®)

Study type

Interventional

Funder types

Other

Identifiers

NCT02022072
2013-A00218-37

Details and patient eligibility

About

Respiratory failure is the most common cause of death in neuromuscular diseases. The aim of this research is to evaluate the thoracopulmonary recruitment by comparison of inspiratory vital capacity (VC ins)and inspiratory/expiratory vital capacity (VC ins-ex) with the vital capacity (VC) according to pathology and severity of pulmonary damage of patients with neuromuscular diseases. The methodology consists in realize VC by support of inspiratory/expiratory pressures, while the patient is passive and realizing a maximal inspiratory/expiratory effort simultaneously, with the aid of mechanical insufflation/exsufflation device (Cough Assist®). The evaluation will last for 30 minutes and the non-inclusion criteria are those for an insufflation. The study hypothesis is that long term insufflation/exsufflation device use could improve thoracopulmonary mobility.

Enrollment

66 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • consent form signature
  • Men and women aged over or equal to 18 years old
  • Medical examination before the research
  • Negative results of tests of pregnancy for the women at age to procreate or taking an effective contraceptive
  • Patients with neuromuscular pathologies without tracheostmy - Vital Capacity < 80% of theoretical value

Exclusion criteria

  • Refuse to participate at the research
  • Patient under guardianship or under trusteeship
  • pregnant Women
  • Patients unable to cooperate
  • Patients without a security social scheme (as beneficiary or bearer of rights)
  • Usual contra-indications for an insufflation (haemoptise, recent pneumothorax, pulmonary emphysema, pleuresy, nausea, chronic obstructive pulmonary diseasee or asthma, recent lobectomy, intracranial hypertension, troubles of consciousness, unable to talk)

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

66 participants in 1 patient group

measure of assisted vital capacity by mechanical insufflation
Other group
Description:
measure of assisted vital capacity by a mechanical insufflation/exsufflation
Treatment:
Device: measures of assisted vital capacity by a mechanical insufflation/exsufflation (Cough Assist®)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems